- £414.57m
- £408.97m
- £240.30m
Annual income statement for MHA, fiscal year end - March 31st, GBP millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PRESS | ARS |
| Standards: | IFRS | IFRS | IFRS | — | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 87.8 | 111 | 149 | 216 | 240 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 54.5 | 65.1 | 91.3 | 136 | 201 |
| Operating Profit | 33.3 | 45.7 | 58.1 | 79.4 | 39.6 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 32.3 | 44.9 | 58.2 | 85.9 | 36.3 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 31.7 | 44 | 56.3 | 83.1 | 28.1 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 31.7 | 44 | 56.3 | 83.1 | 28.1 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 31.7 | 44 | 56.3 | 83.1 | 28.1 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.117 | 0.163 | 0.208 | 0.307 | 0.111 |
| Dividends per Share |